Search results for: Adam Hutchings
Filter search results
In Memoriam Adam Wagstaff 1959-2020
15 May 2020
On the occasion of Adam Wagstaff’s death, Professor Tony Culyer reflects on his vast legacy to health economics, from Tony’s perspective of having been Adam’s PhD supervisor as well as…
Using MCDA to Assess the Value of Treatments for Rare Diseases
5 December 2013
…Garau, Claude Schmitt, Alastair Kent, Adam Hutchings. (2013) A Pilot study of multi-criteria decision analysis for valuing orphan medicines. Value in Health. doi:10.1016/j.jval.2013.10.002 [An earlier version is available on this website as Research…
Handling Uncertainty in the Results of Economic Evaluation
1 September 1995
…have highlighted a high degree of methodological shortcomings in many studies [Adams at… The recent increase in the number of published economic evaluations has been considerable [Wellcome, 1992; Udvarhelyi et…
Consumer Movement, Health, and the Pharmaceutical Industry
1 January 1983
In his Inquiry into the Nature and Causes of the Wealth of Nations, which was first published in 1776, Adam Smith placed special emphasis on the assertion that the ultimate…
Valuing Orphan Medicines Using Multi-Criteria Decision Analysis
7 May 2013
…registered users. Download: Sussex, J., Rollet, P., Garau, M., Schmitt, C., Kent, A. and Hutchings, A. Multi-criteria decision analysis to value orphan medicines. Research Paper 13/03. London: Office of Health…
OHE at Priorities 2016: Valuing Health at the End of Life and MCDA for Priority Setting
19 September 2016
…Kent, A., Hutchings, A., 2013. A Pilot study of multi-criteria decision analysis for valuing orphan medicines. Value in Health. 16(8), pp.1163-1169 For more information on OHE’s research in these areas, please…